These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease]. Miller A; Weiner HL; Abramsky O Harefuah; 1992 Aug; 123(3-4):110-5. PubMed ID: 1516860 [No Abstract] [Full Text] [Related]
3. The T lymphocyte in experimental allergic encephalomyelitis. Zamvil SS; Steinman L Annu Rev Immunol; 1990; 8():579-621. PubMed ID: 2188675 [No Abstract] [Full Text] [Related]
4. Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. Allegretta M; Albertini RJ; Howell MD; Smith LR; Martin R; McFarland HF; Sriram S; Brostoff S; Steinman L J Clin Invest; 1994 Jul; 94(1):105-9. PubMed ID: 8040252 [TBL] [Abstract][Full Text] [Related]
5. Focusing on the human T cell receptor for antigen. Grunewald J Sarcoidosis; 1994 Mar; 11(1):61-5. PubMed ID: 8036347 [No Abstract] [Full Text] [Related]
6. Antigen-specific immunosuppression: oral tolerance for the treatment of autoimmune disease. Hafler DA; Weiner HL Chem Immunol; 1995; 60():126-49. PubMed ID: 7857525 [No Abstract] [Full Text] [Related]
7. Experimental allergic encephalomyelitis as a guide to the understanding and treatment of multiple sclerosis. Whitaker JN; Mitchell GW Ann Neurol; 1993 Nov; 34(5):636-7. PubMed ID: 8239557 [No Abstract] [Full Text] [Related]
8. [TCR CDR3 motif expression in PLP specific T cell from patients with multiple sclerosis]. Kondo T; Yamamura T; Tahira T Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):666-9. PubMed ID: 8963779 [No Abstract] [Full Text] [Related]
9. T-cell vaccination in multiple sclerosis: immunoregulatory mechanism and prospects for therapy. Zhang J Crit Rev Immunol; 2001; 21(1-3):41-55. PubMed ID: 11642613 [TBL] [Abstract][Full Text] [Related]
10. Immunity to T cell receptor peptides: theory and applications. Offner H; Hashim GA; Vandenbark AA Regul Pept; 1994 May; 51(2):77-90. PubMed ID: 8059014 [TBL] [Abstract][Full Text] [Related]
12. Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes. Jyothi MD; Flavell RA; Geiger TL Nat Biotechnol; 2002 Dec; 20(12):1215-20. PubMed ID: 12426577 [TBL] [Abstract][Full Text] [Related]
13. CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis. Kim G; Tanuma N; Kojima T; Kohyama K; Suzuki Y; Kawazoe Y; Matsumoto Y J Immunol; 1998 Jan; 160(1):509-13. PubMed ID: 9552010 [TBL] [Abstract][Full Text] [Related]
14. Animal models for multiple sclerosis. Owens T Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828 [No Abstract] [Full Text] [Related]
15. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the T cell receptor V gene usage in multiple sclerosis and human autoimmune thyroiditis. Ben-Nun A; Bach MA; Raus J; Davies TF Isr J Med Sci; 1993; 29(2-3):164-7. PubMed ID: 8468172 [No Abstract] [Full Text] [Related]
18. New concepts in the immunopathogenesis of multiple sclerosis. Hemmer B; Archelos JJ; Hartung HP Nat Rev Neurosci; 2002 Apr; 3(4):291-301. PubMed ID: 11967559 [No Abstract] [Full Text] [Related]
19. Vaccination with T-cell receptor peptides. Brostoff S Immunol Ser; 1993; 59():203-18. PubMed ID: 8461389 [No Abstract] [Full Text] [Related]
20. [Perivenous encephalomyelitis and multiple sclerosis]. Werner W Med Klin; 1969 Oct; 64(42):1924-7. PubMed ID: 5357972 [No Abstract] [Full Text] [Related] [Next] [New Search]